RODI FERTILITY

About RODI FERTILITY

RODI Fertility – First-in-Class NK Cell Regulation for Successful Pregnancy

RODI Fertility leads global innovation with patented immunomodulatory technology that regulates Natural Killer (NK) cells—a breakthrough in preventing miscarriage and supporting conception. Our flagship RODI NK plus™ has helped thousands of women&n...

Certifications
  • Country/Region:
    Cyprus
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    1 - 24
Company types
Biopharmaceutical company
Start-up
Primary activities
Biopharmaceutical
Contact info
  • Lapithou 14, office 206A, Engomi-Nicosia,, 2410, Nicosia, Cyprus

Products from RODI FERTILITY (3)

  • RODI NK™

    Product RODI NK™

    Revolutionary Approach to Pregnancy's Greatest Challenge First-in-Class, FIrst -to -Market, Patented technology RODI NK™ addresses "The Immunological Paradox of Pregnancy" - the delicate balance between immune protection and embryo tolerance during the critical first trimester. Specifically formu...

RODI FERTILITY Resources (2)

  • News RODI Fertility: Revolutionizing Reproductive Medicine with Immune-Based Solutions

    RODI Fertility was created to address one of the most persistent gaps in reproductive medicine: women who experience miscarriage, implantation failure, or repeated IVF failure despite “normal” findings. Led by Dr. Barbara Geladakis, RODI pioneered an immune-based approach that reframes fertility care through the lens of reproductive immunology—bringing science, clinical insight, and compassion into one protocol-driven solution.